Our Blog

Bubs aims for China Food and Drug registration

08 Jun 2018 – Bubs Australia (ASX:BUB) has entered into a binding Manufacturing Agreement with Australia Deloraine Dairy as a critical step towards achieving China Food and Drug Administration (CFDA) registration.


Source: Finance News Network

Share this post